Maternal Fetal DNA Microdeletions: Is The Cost & Reliability Justified?
- Sep 16, 2016 8:00 am
© 2016 By Keith S. Wexler, MBA, Maternal Fetal Medicine, Prenatal Diagnosis and Biotech/Life Sciences Consultant, GENASSIST, Inc. Paul Wexler, M.D., F.A.C.O.G., Medical Director, GENASSIST, Inc. Clinical Professor, Department of OB/GYN, University of Colorado Health Sciences Center Clinical Professor, Division of Genetics/Dept. of Pediatrics, Univ. of Colorado/The Children’s Hospital Background: Some Maternal Fetal DNA companies […]
Read more ...